Furthermore, this alternative infection pathway may contribute to the clinical finding that Omicron typically causes milder illness, as it preferentially infects and replicates in the upper airways above the lungs and does not infect TMPRSS2-rich lung cells compared to other variants [42-47]. This evidence concerns the gene TMPRSS2 and infection.